Update: 01.08.2023
Last week: 29 week 2023 (17.07.2023 - 23.07.2023)
Last full month: June 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 57 440 | -7.7% | 2.9% | 0 | 13 511 002 | -9.2% | 3.1% | -0.1 | -7.3% |
| MoM | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| YTD | 2 488 132 | -61.1% | 2.7% | -3.2 | 640 474 820 | -49.4% | 3.2% | -2.4 | -15.3% |
| MAT | 5 930 640 | -59.2% | 3.1% | -3.5 | 1 395 525 960 | -48.3% | 3.4% | -2.7 | -14.0% |
| DEXALGIN | |||||||||
| WoW | 19 018 | -0.0% | 0.4% | 0 | 9 692 741 | -0.1% | 1.1% | 0 | -2.5% |
| MoM | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| YTD | 506 261 | -55.8% | 0.4% | -0.4 | 263 105 726 | -44.6% | 1.1% | -0.9 | -5.4% |
| MAT | 946 321 | -54.6% | 0.4% | -0.4 | 474 983 901 | -43.0% | 1.2% | -0.9 | -6.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 63 562 | -0.0% | 38.3% | -1.3 | 36 197 844 | -1.8% | 44.8% | -1.6 | 3.4% |
| MoM | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| YTD | 1 626 552 | -44.8% | 39.8% | -18.9 | 990 207 620 | -33.4% | 48.1% | -16 | -18.7% |
| MAT | 2 961 537 | -45.8% | 41.7% | -19.9 | 1 711 400 235 | -36.0% | 49.1% | -17.8 | -19.9% |
| ESPUMISAN BABY | |||||||||
| WoW | 25 347 | 6.4% | 36.2% | 1.7 | 17 791 497 | 5.3% | 49.6% | 1.9 | 1.2% |
| MoM | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| YTD | 614 693 | -30.2% | 31.2% | -8.5 | 462 191 459 | -14.8% | 46.7% | -6 | -11.2% |
| MAT | 1 160 118 | -28.3% | 32.5% | -7.8 | 825 132 566 | -15.8% | 47.1% | -6.8 | -11.0% |
| FASTUM | |||||||||
| WoW | 14 932 | -3.8% | 0.9% | 0 | 8 860 082 | -3.7% | 2.1% | 0 | -3.7% |
| MoM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| YTD | 432 851 | -36.1% | 0.9% | -0.4 | 262 105 879 | -23.7% | 2.2% | -0.5 | -3.8% |
| MAT | 796 133 | -38.1% | 0.9% | -0.5 | 464 798 289 | -25.8% | 2.2% | -0.6 | -3.6% |
| IODOMARIN | |||||||||
| WoW | 66 633 | -6.1% | 23.6% | -0.7 | 11 965 474 | -6.1% | 9.7% | -0.5 | -3.4% |
| MoM | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| YTD | 1 973 795 | 16.4% | 22.9% | 4.2 | 361 314 788 | 5.4% | 9.3% | 0.8 | -5.1% |
| MAT | 3 571 045 | 8.4% | 23.0% | 2.5 | 658 664 335 | 2.9% | 9.6% | 0.2 | -3.2% |
| LIOTON | |||||||||
| WoW | 22 612 | 2.1% | 2.2% | 0.1 | 27 854 776 | 2.9% | 4.6% | 0.2 | -2.4% |
| MoM | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| YTD | 547 693 | -35.1% | 2.0% | -0.8 | 685 827 529 | -19.7% | 4.5% | -0.5 | -11.1% |
| MAT | 955 403 | -38.4% | 2.0% | -0.9 | 1 138 890 246 | -22.4% | 4.3% | -1 | -11.0% |
| MEZYM | |||||||||
| WoW | 219 840 | -3.6% | 18.0% | -0.1 | 36 758 631 | -3.1% | 13.0% | 0.4 | -3.0% |
| MoM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| YTD | 6 180 875 | -49.3% | 18.4% | -11.1 | 981 266 354 | -47.4% | 12.6% | -8.5 | -18.7% |
| MAT | 11 344 113 | -51.1% | 18.7% | -12.2 | 1 759 955 082 | -48.1% | 13.0% | -9.5 | -19.2% |
| MIG 400 | |||||||||
| WoW | 95 284 | 7.9% | 2.0% | 0.2 | 11 842 188 | -1.6% | 1.4% | 0 | -2.5% |
| MoM | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| YTD | 3 335 780 | -35.1% | 2.4% | -1.1 | 426 716 115 | -29.2% | 1.9% | -0.8 | -5.4% |
| MAT | 6 589 486 | -35.1% | 2.6% | -1.1 | 818 029 477 | -29.6% | 2.0% | -0.9 | -6.3% |
| PROSTAMOL | |||||||||
| WoW | 22 242 | -3.0% | 14.4% | -0.4 | 35 561 156 | -3.8% | 16.6% | -0.3 | -0.4% |
| MoM | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| YTD | 597 376 | -41.6% | 13.2% | -7.5 | 897 238 259 | -37.5% | 14.6% | -7.4 | -8.3% |
| MAT | 1 121 847 | -44.2% | 13.9% | -8.6 | 1 626 963 343 | -39.7% | 15.0% | -8.8 | -9.4% |
| RESPERO MYRTOL | |||||||||
| WoW | 12 417 | -1.5% | 8.2% | 0.4 | 6 749 552 | -0.5% | 8.9% | 0.6 | -6.4% |
| MoM | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
| YTD | 568 029 | -23.5% | 7.0% | -1.7 | 312 793 137 | -9.5% | 7.7% | -0.9 | -4.6% |
| MAT | 1 127 122 | -9.1% | 7.4% | -0.5 | 590 579 294 | 3.5% | 8.0% | 0.2 | -3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 2 488 132 | -61.1% | 2.7% | -3.2 | 640 474 820 | -49.4% | 3.2% | -2.4 | -15.3% |
| DEXALGIN | 506 261 | -55.8% | 0.4% | -0.4 | 263 105 726 | -44.6% | 1.1% | -0.9 | -5.4% |
| ESPUMISAN (ADULTS) | 1 626 552 | -44.8% | 39.8% | -18.9 | 990 207 620 | -33.4% | 48.1% | -16 | -18.7% |
| ESPUMISAN BABY | 614 693 | -30.2% | 31.2% | -8.5 | 462 191 459 | -14.8% | 46.7% | -6 | -11.2% |
| FASTUM | 432 851 | -36.1% | 0.9% | -0.4 | 262 105 879 | -23.7% | 2.2% | -0.5 | -3.8% |
| IODOMARIN | 1 973 795 | 16.4% | 22.9% | 4.2 | 361 314 788 | 5.4% | 9.3% | 0.8 | -5.1% |
| LIOTON | 547 693 | -35.1% | 2.0% | -0.8 | 685 827 529 | -19.7% | 4.5% | -0.5 | -11.1% |
| MEZYM | 6 180 875 | -49.3% | 18.4% | -11.1 | 981 266 354 | -47.4% | 12.6% | -8.5 | -18.7% |
| MIG | 3 335 780 | -35.1% | 2.4% | -1.1 | 426 716 115 | -29.2% | 1.9% | -0.8 | -5.4% |
| PROSTAMOL | 597 376 | -41.6% | 13.2% | -7.5 | 897 238 259 | -37.5% | 14.6% | -7.4 | -8.3% |
| RESPERO MYRTOL | 568 029 | -23.5% | 7.0% | -1.7 | 312 793 137 | -9.5% | 7.7% | -0.9 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 930 640 | -59.2% | 3.1% | -3.5 | 1 395 525 960 | -48.3% | 3.4% | -2.7 | -14.0% |
| DEXALGIN | 946 321 | -54.6% | 0.4% | -0.4 | 474 983 901 | -43.0% | 1.2% | -0.9 | -6.3% |
| ESPUMISAN (ADULTS) | 2 961 537 | -45.8% | 41.7% | -19.9 | 1 711 400 235 | -36.0% | 49.1% | -17.8 | -19.9% |
| ESPUMISAN BABY | 1 160 118 | -28.3% | 32.5% | -7.8 | 825 132 566 | -15.8% | 47.1% | -6.8 | -11.0% |
| FASTUM | 796 133 | -38.1% | 0.9% | -0.5 | 464 798 289 | -25.8% | 2.2% | -0.6 | -3.6% |
| IODOMARIN | 3 571 045 | 8.4% | 23.0% | 2.5 | 658 664 335 | 2.9% | 9.6% | 0.2 | -3.2% |
| LIOTON | 955 403 | -38.4% | 2.0% | -0.9 | 1 138 890 246 | -22.4% | 4.3% | -1 | -11.0% |
| MEZYM | 11 344 113 | -51.1% | 18.7% | -12.2 | 1 759 955 082 | -48.1% | 13.0% | -9.5 | -19.2% |
| MIG | 6 589 486 | -35.1% | 2.6% | -1.1 | 818 029 477 | -29.6% | 2.0% | -0.9 | -6.3% |
| PROSTAMOL | 1 121 847 | -44.2% | 13.9% | -8.6 | 1 626 963 343 | -39.7% | 15.0% | -8.8 | -9.4% |
| RESPERO MYRTOL | 1 127 122 | -9.1% | 7.4% | -0.5 | 590 579 294 | 3.5% | 8.0% | 0.2 | -3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 57 440 | -7.7% | 2.9% | 0 | 13 511 002 | -9.2% | 3.1% | -0.1 | -7.3% |
| DEXALGIN | 19 018 | -0.0% | 0.4% | 0 | 9 692 741 | -0.1% | 1.1% | 0 | -2.5% |
| ESPUMISAN (ADULTS) | 63 562 | -0.0% | 38.3% | -1.3 | 36 197 844 | -1.8% | 44.8% | -1.6 | 3.4% |
| ESPUMISAN BABY | 25 347 | 6.4% | 36.2% | 1.7 | 17 791 497 | 5.3% | 49.6% | 1.9 | 1.2% |
| FASTUM | 14 932 | -3.8% | 0.9% | 0 | 8 860 082 | -3.7% | 2.1% | 0 | -3.7% |
| IODOMARIN | 66 633 | -6.1% | 23.6% | -0.7 | 11 965 474 | -6.1% | 9.7% | -0.5 | -3.4% |
| LIOTON | 22 612 | 2.1% | 2.2% | 0.1 | 27 854 776 | 2.9% | 4.6% | 0.2 | -2.4% |
| MEZYM | 219 840 | -3.6% | 18.0% | -0.1 | 36 758 631 | -3.1% | 13.0% | 0.4 | -3.0% |
| MIG | 95 284 | 7.9% | 2.0% | 0.2 | 11 842 188 | -1.6% | 1.4% | 0 | -2.5% |
| PROSTAMOL | 22 242 | -3.0% | 14.4% | -0.4 | 35 561 156 | -3.8% | 16.6% | -0.3 | -0.4% |
| RESPERO MYRTOL | 12 417 | -1.5% | 8.2% | 0.4 | 6 749 552 | -0.5% | 8.9% | 0.6 | -6.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| DEXALGIN | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| ESPUMISAN (ADULTS) | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| ESPUMISAN BABY | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| FASTUM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| IODOMARIN | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| LIOTON | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| MEZYM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| MIG | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| PROSTAMOL | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| RESPERO MYRTOL | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs